Related Experiment Video
Updated: Mar 8, 2026

Generation and Expansion of Primary, Malignant Pleural Mesothelioma Tumor Lines
Published on: April 21, 2022
Morcellating uterine mesenchymal tumors: The pathologist's view
Kitty Pavlakis1,2, Irini Messini1, Petros Yiannou1
1Pathology Department, IASO Women's Hospital, Maroussi, Greece.
Diagnosing uterine mesenchymal tumors in morcellated tissue presents challenges. Pathologists may over- or underdiagnose conditions like leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) due to histological limitations.
Area of Science:
- Gynecologic Pathology
- Surgical Pathology
- Oncology
Background:
- Morcellation of uterine specimens is common in gynecologic surgery.
- Histological evaluation of morcellated tissue poses diagnostic challenges.
- Accurate diagnosis is crucial for patient management and prognosis.
Purpose of the Study:
- To identify histological challenges in diagnosing uterine mesenchymal tumors from morcellated specimens.
- To assess the incidence of unexpected malignancy in morcellated uterine tissues.
- To analyze discrepancies between initial and subsequent diagnoses.
Main Methods:
- Retrospective review of 631 cases of morcellated uteri (2008-2014).
- Noted incidence of leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS).
- Included cases with diagnostic discrepancies between morcellated and subsequent findings.
Main Results:
- Three LMS and five ESS diagnoses were confirmed.
- Malignant tumors were found in patients aged 25-48.
- Several cases showed diagnostic discrepancies, including ESS misdiagnosed as benign nodules and vice versa.
Conclusions:
- Malignant endometrial stromal and smooth muscle tumors can occur in young patients.
- Histological limitations in morcellated material can lead to diagnostic errors (over- or underdiagnosis).
- Careful pathological review is essential for accurate diagnosis of uterine mesenchymal tumors.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019